AI Strengthens Analytics for Life Sciences, Healthcare
The 2024 ISG Provider Lens™ global Specialty Analytics Services report highlights increased investment in advanced analytics by life sciences and healthcare enterprises to boost competitiveness. Key findings include:
1. Rapid improvements in AI, including generative AI, are helping companies better understand customer needs and make informed decisions.
2. Firms are applying advanced analytics and AI to research, operations, and product commercialization as part of data modernization strategies.
3. Specialty analytics providers are empowering companies to implement custom-built advanced analytics solutions.
4. AI is being used for various applications, including drug demand forecasting, supply chain monitoring, and clinical data analysis.
5. Healthcare providers are using AI tools to boost efficiency and deliver better care.
The report also identifies key future advancements, including increased use of telehealth and personalized precision medicine.
Il rapporto globale 2024 ISG Provider Lens™ sui Servizi di Analisi Specializzata mette in evidenza l'aumento degli investimenti in analisi avanzate da parte delle imprese nel settore delle scienze della vita e della sanità per migliorare la competitività. I principali risultati includono:
1. Miglioramenti rapidi nell'IA, inclusa l'IA generativa, stanno aiutando le aziende a comprendere meglio le esigenze dei clienti e a prendere decisioni informate.
2. Le aziende stanno applicando analisi avanzate e IA nella ricerca, nelle operazioni e nella commercializzazione dei prodotti come parte delle strategie di modernizzazione dei dati.
3. I fornitori di analisi specializzate stanno consentendo alle aziende di implementare soluzioni di analisi avanzate su misura.
4. L'IA viene utilizzata per varie applicazioni, tra cui la previsione della domanda di farmaci, il monitoraggio della catena di approvvigionamento e l'analisi dei dati clinici.
5. I fornitori di assistenza sanitaria stanno usando strumenti di IA per aumentare l'efficienza e fornire una migliore assistenza.
Il rapporto identifica anche i principali sviluppi futuri, tra cui un uso maggiore della telemedicina e della medicina di precisione personalizzata.
El informe global de Servicios de Análisis Especializados 2024 ISG Provider Lens™ destaca el aumento de inversiones en análisis avanzados por parte de empresas de ciencias de la vida y atención médica para mejorar la competitividad. Los hallazgos clave incluyen:
1. Mejoras rápidas en IA, incluida la IA generativa, están ayudando a las empresas a comprender mejor las necesidades del cliente y tomar decisiones informadas.
2. Las empresas están aplicando análisis avanzados e IA a la investigación, operaciones y comercialización de productos como parte de las estrategias de modernización de datos.
3. Los proveedores de análisis especializados están empoderando a las empresas para implementar soluciones de análisis avanzadas personalizadas.
4. La IA se utiliza para diversas aplicaciones, incluyendo la previsión de la demanda de medicamentos, el monitoreo de la cadena de suministro y el análisis de datos clínicos.
5. Los proveedores de atención médica están utilizando herramientas de IA para aumentar la eficiencia y ofrecer una mejor atención.
El informe también identifica los principales avances futuros, incluyendo un mayor uso de la telemedicina y la medicina de precisión personalizada.
2024 ISG Provider Lens™ 글로벌 전문 분석 서비스 보고서는 생명 과학 및 의료 기업들이 경쟁력을 높이기 위해 고급 분석에 대한 투자 증가를 강조합니다. 주요 연구 결과는 다음과 같습니다:
1. 생성적 AI를 포함한 AI의 빠른 발전이 기업들이 고객의 요구를 더 잘 이해하고 정보에 기반한 결정을 내리는 데 도움을 주고 있습니다.
2. 기업들은 데이터 현대화 전략의 일환으로 연구, 운영 및 제품 상용화에 고급 분석 및 AI를 적용하고 있습니다.
3. 전문 분석 제공업체들은 기업들이 맞춤형 고급 분석 솔루션을 구현할 수 있도록 지원하고 있습니다.
4. AI는 약물 수요 예측, 공급망 모니터링, 임상 데이터 분석 등 다양한 용도로 사용되고 있습니다.
5. 의료 제공업체들은 AI 도구를 활용하여 효율성을 높이고 더 나은 치료를 제공하고 있습니다.
보고서는 또한 원격 의료 및 개인 맞춤형 정밀 의학의 활용 증가를 포함한 주요 미래 발전을 식별하고 있습니다.
Le rapport mondial 2024 ISG Provider Lens™ sur les Services d'Analytique Spécialisée met en lumière l'augmentation des investissements dans l'analytique avancée par les entreprises des sciences de la vie et de la santé pour renforcer leur compétitivité. Les principales conclusions comprennent :
1. Des améliorations rapides dans l'IA, y compris l'IA générative, aident les entreprises à mieux comprendre les besoins des clients et à prendre des décisions éclairées.
2. Les entreprises appliquent l'analytique avancée et l'IA à la recherche, aux opérations et à la commercialisation de produits dans le cadre de stratégies de modernisation des données.
3. Les fournisseurs d'analytique spécialisée permettent aux entreprises de mettre en œuvre des solutions d'analytique avancée sur mesure.
4. L'IA est utilisée pour diverses applications, y compris la prévision de la demande de médicaments, la surveillance de la chaîne d'approvisionnement et l'analyse des données cliniques.
5. Les fournisseurs de soins de santé utilisent des outils d'IA pour améliorer l'efficacité et offrir un meilleur soin.
Le rapport identifie également des avancées futures clés, notamment une utilisation accrue de la télémédecine et de la médecine de précision personnalisée.
Der globale Bericht zu den 2024 ISG Provider Lens™ Spezialanalysediensten hebt die gestiegenen Investitionen in fortgeschrittene Analytik durch Unternehmen in den Bereichen Lebenswissenschaften und Gesundheitswesen hervor, um die Wettbewerbsfähigkeit zu steigern. Wesentliche Erkenntnisse sind:
1. Schnelle Fortschritte in der KI, einschließlich generativer KI, unterstützen Unternehmen dabei, die Bedürfnisse der Kunden besser zu verstehen und informierte Entscheidungen zu treffen.
2. Unternehmen wenden fortgeschrittene Analytik und KI in der Forschung, den Abläufen und der Produktvermarktung im Rahmen von Datenmodernisierungsstrategien an.
3. Spezialanalysenanbieter befähigen Unternehmen, maßgeschneiderte Lösungen für fortgeschrittene Analytik zu implementieren.
4. KI wird für verschiedene Anwendungen eingesetzt, einschließlich der Prognose von Arzneimittelbedarf, der Überwachung der Lieferkette und der Analyse klinischer Daten.
5. Gesundheitsdienstleister nutzen KI-Tools zur Steigerung der Effizienz und zur Verbesserung der Patientenversorgung.
Der Bericht identifiziert auch wichtige zukünftige Fortschritte, einschließlich der erhöhten Nutzung von Telemedizin und personalisierter Präzisionsmedizin.
- Increased investment in advanced analytics capabilities by life sciences and healthcare enterprises
- Application of AI and advanced analytics to research, operations, and product commercialization
- Use of AI for accelerating R&D, finding hidden patterns, and forecasting trends
- Implementation of AI tools in healthcare to boost efficiency and deliver better care
- Development of GenAI solutions and LLMs trained on healthcare-specific datasets
- None.
Insights
The report highlights a significant trend in life sciences and healthcare: increased investment in advanced analytics and AI. This shift is driven by the need for competitive advantage and improved decision-making. Key points include:
- Custom-built analytics solutions are preferred over off-the-shelf software due to industry-specific challenges.
- AI and advanced analytics are being applied to research, operations and product commercialization.
- There's a focus on building strong data foundations for comprehensive views of clinical and commercial data.
- Applications range from drug demand forecasting to clinical trial design and monitoring.
- GenAI and LLMs are emerging as powerful tools for data analysis and streamlining care delivery.
This trend suggests potential growth for companies like ISG (III) that provide technology research and advisory services. The increasing demand for specialized analytics solutions could drive business for firms offering expertise in this area. However, the impact may be gradual as companies implement these technologies incrementally.
The article underscores the transformative potential of AI and advanced analytics in healthcare and life sciences. Key technological advancements include:
- Integration of AI for faster, more accurate diagnoses and treatment predictions
- Use of large language models (LLMs) for clinical trial design and monitoring
- Development of GenAI solutions trained on healthcare-specific datasets
- Increased adoption of telehealth and precision medicine
- Utilization of data from wearables for personalized care
These developments indicate a growing market for specialized AI and analytics solutions in healthcare. For ISG (III), this presents opportunities to expand its advisory services in emerging tech areas. The company's position as a technology research firm could be strengthened by focusing on these high-demand, specialized analytics services. However, competition in this space is likely to intensify, requiring continuous innovation and expertise development.
Enterprises seek specialized solutions, comprehensive strategies for using data to stay ahead of the market, ISG Provider Lens™ report says
The 2024 ISG Provider Lens™ global Specialty Analytics Services — Life Sciences and Healthcare report finds that rapid improvements in AI, including generative AI (GenAI), promise to help companies better understand customer needs and make more informed decisions. Firms in these sectors are incrementally applying advanced analytics and AI to research, operations and product commercialization as part of far-reaching data modernization strategies.
“The unique challenges of life sciences and healthcare require more than standard, off-the-shelf analytics software,” said Jenn Stein, ISG partner and life sciences industry lead. “Specialty analytics providers empower these companies to implement custom-built advanced analytics solutions with confidence.”
A strong data foundation can give companies a comprehensive view of clinical and commercial data coming from both internal and external sources and make it available to non-technical employees, the report says. With advanced analytics, they can use this data to accelerate R&D, find hidden patterns, forecast trends and optimize responses to the market.
Life sciences firms are using modern analytics in a wide range of applications, including forecasting drug demand, monitoring supply chains and assessing medication benefits and risks, ISG says. AI is proving especially powerful for analyzing clinical data to identify potential drug targets, and large language models (LLMs) can help companies design and monitor clinical trials.
Healthcare providers are beginning to use AI tools to boost efficiency and deliver better care, among other applications, the report says. AI can help providers analyze medical records and other patient data to produce accurate diagnoses more quickly, better predict the course of a disease and shorten the time to treatment. GenAI solutions may streamline care delivery by extracting and summarizing clinical notes.
The report identifies several key advancements likely to shape the life sciences and healthcare industries in the coming years, including increased use of telehealth to improve patient outcomes and personalized precision medicine using data from wearables and other sources. Development of GenAI solutions is expected to continue, with specialty analytics providers already investing in LLMs trained on healthcare-specific datasets.
“Life sciences and healthcare companies continue to partner with specialist providers on AI and advanced analytics,” said Jan Erik Aase, partner and global leader, ISG Provider Lens Research. “Providers with proven expertise in areas like GenAI, compliance and governance are making this future possible.”
The report also explores other life sciences and healthcare analytics trends, including the growing use of advanced analytics to personalize market outreach initiatives and detect abuse in claims processing.
For more insights into the analytics challenges facing life sciences and healthcare enterprises, including how to get maximum value from complex and growing datasets, plus ISG’s advice for addressing these issues, see the ISG Provider Lens™ Focal Points briefing here.
The 2024 ISG Provider Lens™ global Specialty Analytics Services — Life Sciences and Healthcare report evaluates the capabilities of 19 providers in one quadrant: Life Sciences and Healthcare.
The report names Axtria, CitiusTech, Fractal Analytics, HARMAN Digital Transformation Solutions, MathCo, Quantiphi, Virtusa and ZS as Leaders in the quadrant.
In addition, Marlabs is named as a Rising Star, a company with a “promising portfolio” and “high future potential” by ISG’s definition.
Customized versions of the report are available from Navikenz, CitiusTech and Marlabs.
The 2024 ISG Provider Lens™ global Specialty Analytics Services — Life Sciences and Healthcare report is available to subscribers or for one-time purchase on this webpage.
About ISG Provider Lens™ Research
The ISG Provider Lens™ Quadrant research series is the only service provider evaluation of its kind to combine empirical, data-driven research and market analysis with the real-world experience and observations of ISG's global advisory team. Enterprises will find a wealth of detailed data and market analysis to help guide their selection of appropriate sourcing partners, while ISG advisors use the reports to validate their own market knowledge and make recommendations to ISG's enterprise clients. The research currently covers providers offering their services globally, across
About ISG
ISG (Information Services Group) (Nasdaq: III) is a leading global technology research and advisory firm. A trusted business partner to more than 900 clients, including more than 75 of the world’s top 100 enterprises, ISG is committed to helping corporations, public sector organizations, and service and technology providers achieve operational excellence and faster growth. The firm specializes in digital transformation services, including AI, cloud and data analytics; sourcing advisory; managed governance and risk services; network carrier services; strategy and operations design; change management; market intelligence and technology research and analysis. Founded in 2006, and based in
View source version on businesswire.com: https://www.businesswire.com/news/home/20241009277406/en/
Press Contacts:
Will Thoretz, ISG
+1 203 517 3119
will.thoretz@isg-one.com
Julianna Sheridan, Matter Communications for ISG
+1 978 518 4520
isg@matternow.com
Source: Information Services Group, Inc.
FAQ
What are the key findings of the 2024 ISG Provider Lens™ global Specialty Analytics Services report for life sciences and healthcare?
How is AI being used in life sciences and healthcare according to the ISG report?
What future advancements does the ISG report predict for life sciences and healthcare industries?
Which companies are named as Leaders in the Life Sciences and Healthcare quadrant of the ISG Provider Lens™ report?
What is the stock symbol for Information Services Group (ISG) mentioned in the press release?
